Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio Protocol (BIO) vs KAITO (KAITO) Price & Performance

Bio ProtocolTrade
KAITOTrade

Price performance (Past 24H)

Key statistics

Bio Protocol vs KAITO — how do they compare? Bio Protocol trades at Rp497.26 (market cap Rp1,12T, Rp283,83M 24h volume), while KAITO trades at Rp12,560 (market cap Rp3,04T, Rp485,59M 24h volume). The key difference: KAITO is far larger — about 2.7× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 241,4M / 1B KAITO (25%) for KAITO. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and KAITO for 11 Days on average.

BIOKAITO
Market Cap
Rp1,12TRp3,04T
Volume (24h)
Rp283,83MRp485,59M
Circulating Supply
2,2B / 3,3B BIO (68%)241,4M / 1B KAITO (25%)
Typical Hold Time
16 Days11 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bio Protocol

Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.

Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.

KAITO

KAITO is trading at Rp12,361 with a bullish technical signal, supported by strong moving averages and ADX readings indicating a robust trend. The token's market cap stands at Rp2.99 trillion, with a circulating supply of 241.4 million out of 1 million max supply, reflecting a 25% circulation rate. No major protocol updates or ecosystem news were reported recently, but the asset shows resilience above key support levels.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include low liquidity and regulatory uncertainty. Key opportunities lie in potential breakout above resistance, while major risks involve high volatility and limited on-chain activity. Investors should monitor exchange listings and community engagement for catalysts.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BIO
13% Buy87% Sell
Avg holding period · 16 Days
KAITO
28% Buy72% Sell
Avg holding period · 11 Days

Top news

Latest headlines on both assets

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO

About KAITO

KAITO is the native token and foundational component of the AI-powered InfoFi network. It serves several important functions: aligning incentives, empowering participants, and fostering the development of a fair and efficient AI-driven information finance ecosystem.

Read more on KAITO